Verséa Ophthalmics invites you to attend the Hawaiian Eye 2023 – Disruptive Innovations Symposium on January 16th from 1pm – 2:30pm HST where Dr. Rob Sambursky, our President, will be presenting the latest Eye Care innovations:

• Novel, Tear-based Point-of-care (POC) diagnostic platform with 2 quantitative tests,
• Complementary regenerative therapeutics.

These innovative solutions will help you enhance clinical management and treatment decisions, resulting in better patient care and satisfaction.

We are looking forward to meeting you!

Aloha!

 

 

………….

About Verséa™ Ophthalmics
Verséa™ Ophthalmics, LLC, a business division of Verséa Health, Inc. (“Verséa”), is one of the fastest growing U.S. healthcare companies on a mission to revolutionize eye care. It is specialized in the sale and distribution of innovative solutions for the diagnosis, treatment, and management of ocular surface diseases. To learn more, visit Verséa™ Ophthalmics webpage